![Lin Yu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lin Yu
Direktor/Vorstandsmitglied bei GATC Health Corp.
Profil
Lin Yu is currently working as a Director at GATC Health Corp.
Dr. Yu has a graduate and doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from The Cooper Union for the Advancement of Science & Art.
Aktive Positionen von Lin Yu
Unternehmen | Position | Beginn |
---|---|---|
GATC Health Corp.
![]() GATC Health Corp. BiotechnologyHealth Technology GATC Health Corp. is a technology company based in Irvine, CA that uses whole genome analysis and multiomics-based artificial intelligence to revolutionize disease detection and drug discovery. The company's validated and proprietary Multiomics Advanced Technology™ (MAT) platform simulates human biochemistry's billions of interactions for accurate and rapid disease prediction, novel target identification, and drug discovery and development. GATC Health envisions a future of medicine where health is protected, disease is reversed, and every person's unique biology is treated with precision. The CEO of the company is Jeff Moses. | Direktor/Vorstandsmitglied | 23.02.2023 |
Ausbildung von Lin Yu
The Trustees of Columbia University in The City of New York | Doctorate Degree |
The Cooper Union for the Advancement of Science & Art | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
GATC Health Corp.
![]() GATC Health Corp. BiotechnologyHealth Technology GATC Health Corp. is a technology company based in Irvine, CA that uses whole genome analysis and multiomics-based artificial intelligence to revolutionize disease detection and drug discovery. The company's validated and proprietary Multiomics Advanced Technology™ (MAT) platform simulates human biochemistry's billions of interactions for accurate and rapid disease prediction, novel target identification, and drug discovery and development. GATC Health envisions a future of medicine where health is protected, disease is reversed, and every person's unique biology is treated with precision. The CEO of the company is Jeff Moses. | Health Technology |